Skip to content

JiuShen acupuncture for post-stroke mild cognitive impairment: a Randomized Controlled Trial

JiuShen acupuncture for post-stroke mild cognitive impairment: a Randomized Controlled Trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400080973
Enrollment
Unknown
Registered
2024-02-19
Start date
2024-02-25
Completion date
Unknown
Last updated
2024-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-stroke mild cognitive impairment

Interventions

Jiushen acupuncture group:conventional treatment Jiushen acupuncture
conventional treatment group:conventional treatment conventional acupuncture

Sponsors

Department of Acupuncture and Rehabilitation of Guangdong Second Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) Meets the diagnostic criteria of traditional Chinese and Western medicine; (2) Age range from 18 to 70 years old, regardless of gender; (3) The MoCA Montreal Cognitive Assessment Scale scores 18-26 points; (4) MMSE scale screening17 points, primary school group (education years = 6 years)>20 points, secondary school and above (education years>6 years)>24 points); (5) No history of mental illness, clear consciousness, stable vital signs, and able to cooperate in completing the scale evaluation; (6) Patients diagnosed with cerebral infarction (or cerebral hemorrhage) during the recovery period within 6 months after stroke; (7) Patients and their families voluntarily participate, are aware of the treatment process and risks, and sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1) Individuals with severe diseases such as heart, liver, kidney, and malignant tumors; (2) Individuals with obvious hearing and visual abnormalities, aphasia, severe cognitive impairment, etc. who cannot cooperate with the scale assessment; (3) Cognitive impairment that existed before the onset of the disease or was caused by other reasons after the onset of the disease (such as Alzheimer's disease, traumatic brain injury, encephalitis, poisoning, white matter degeneration disease, etc.); (4) Fear of acupuncture, prone to dizziness and needle stagnation; (5) Participated in other clinical trials within the past 3 months; (6) Individuals with unclear consciousness, abnormal vital signs, and the need for rescue at any time.

Design outcomes

Primary

MeasureTime frame
The MoCA Montreal Cognitive Assessment Scale scores ;8-OHdG;Calcium-binding protein S100ß;

Secondary

MeasureTime frame
mini-mental state estimate scores ;modified Barthel scores;

Countries

China

Contacts

Public ContactTongLiu

Guangdong Second Hospital of Traditional Chinese Medicine

Liutongmama@163.com+86 18 319 673 3139

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026